Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer. (nejm.org)

Authors: Powles T … Drakaki A Journal: New England Journal of Medicine Published: 2026-10-24 DOI: https://doi.org/10.1056/NEJMoa2608323